150 related articles for article (PubMed ID: 38544527)
1. Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program.
Loonen AJM; Verhagen F; Luijten-de Vrije I; Lentjes-Beer M; Huijsmans CJ; van den Brule AJC
Front Cell Infect Microbiol; 2024; 14():1330844. PubMed ID: 38544527
[TBL] [Abstract][Full Text] [Related]
2. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
3. The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.
Vielot N; Hudgens MG; Mugo N; Chitwa M; Kimani J; Smith J
Sex Transm Dis; 2015 Jun; 42(6):305-11. PubMed ID: 25970306
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali.
Jary A; Teguete I; Sidibé Y; Kodio A; Dolo O; Burrel S; Boutolleau D; Beauvais-Remigereau L; Sayon S; Kampo M; Traoré FT; Sylla M; Achenbach C; Murphy R; Berçot B; Bébéar C; Calvez V; Marcelin AG; Maiga AI
Int J Infect Dis; 2021 Jul; 108():610-616. PubMed ID: 34146691
[TBL] [Abstract][Full Text] [Related]
5. Association between visual inspection of the cervix with acetic acid examination and high-risk human papillomavirus infection, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Papua New Guinea.
Vallely AJ; Toliman PJ; Ryan C; Rai G; Wapling J; Gabuzzi J; Kumbia A; Kombuk B; Kombati Z; Vallely LM; Kelly-Hanku A; Wand H; Tabrizi SN; Mola GDL; Kaldor JM
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):576-581. PubMed ID: 29380356
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
van de Wijgert JHHM; Gill AC; Chikandiwa A; Verwijs MC; Kelly HA; Omar T; Delany-Moretlwe S; Segondy M; Francis S; Darby AC; Mayaud P;
AIDS; 2020 Jan; 34(1):115-125. PubMed ID: 31567164
[TBL] [Abstract][Full Text] [Related]
7. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
9. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus.
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
Clin Microbiol Infect; 2018 Dec; 24(12):1328-1332. PubMed ID: 29559392
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers.
Cameron JE; Rositch AF; Vielot NA; Mugo NR; Kwatampora JKL; Waweru W; Gilliland AE; Hagensee ME; Smith JS
Sex Transm Dis; 2018 Oct; 45(10):666-672. PubMed ID: 29664764
[TBL] [Abstract][Full Text] [Related]
11. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
Tranberg M; Jensen JS; Bech BH; Andersen B
BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
[TBL] [Abstract][Full Text] [Related]
12. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
14. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ
Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286
[TBL] [Abstract][Full Text] [Related]
15. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia Trachomatis Infection in High-Risk Human Papillomavirus Based on Cervical Cytology Specimen.
Sangpichai S; Patarapadungkit N; Pientong C; Ekalaksananan T; Chaiwiriyakul S; Thongbor R; Sirivech P; Jangsiriwitayakorn P; Triamwittayanon T
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3843-3847. PubMed ID: 31870131
[TBL] [Abstract][Full Text] [Related]
18. [Association of human papillomavirus infection with other microbial pathogens in gynecology].
Zheng MY; Zhao HL; Di JP; Lin G; Lin Y; Lin X; Zheng MQ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):424-8. PubMed ID: 21029592
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.
Berger L; Wolf-Breitinger M; Weiß C; Tuschy B; Berlit S; Sütterlin M; Spaich S
Cancer Causes Control; 2023 May; 34(5):469-477. PubMed ID: 36854989
[TBL] [Abstract][Full Text] [Related]
20. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
